U.S. revenue was $569 million and increased 6 percent compared to the prior-year Q4 period. U.S. Wholesale revenue increased ...
Arbutus Biopharma Corporation ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company focused on infectious disease, today announced changes to its board of directors and the ...
StockStory.org on MSN2h
Kontoor Brands (NYSE:KTB) Reports Q4 In Line With ExpectationsClothing company Kontoor Brands (NYSE:KTB) in Q4 CY2024, with sales up 4.4% year on year to $699.3 million. On the other hand ...
Kontoor Brands, Inc. (NYSE: KTB), a global lifestyle apparel company, with a portfolio led by two of the world’s most iconic consumer brands, Wrangler® and Lee®, today reported financial results for ...
U.S. revenue was up 6% year-over-year to $569 million. U.S. wholesale revenue increased 5% during the quarter. Direct-to-consumer increased 11% driven by a 16% increase in digital and a 1% increase in ...
Kontoor expects full-year earnings in the range of $5.20 to $5.30 per share, with revenue in the range of $2.63 billion to $2.69 billion. This story was generated by Automated Insights ( ...
Kontoor Brands Inc (NYSE:KTB) is set to release its Q4 2024 earnings on Feb 25, 2025. The consensus estimate for Q4 2024 ...
21h
Zacks.com on MSNGIL vs. KTB: Which Stock Is the Better Value Option?Investors interested in Textile - Apparel stocks are likely familiar with Gildan Activewear (GIL) and Kontoor Brands (KTB). But which of these two stocks is more attractive to value investors? We'll ...
Kontoor Brands by a significant percentage in the fourth quarter.,Institutions collectively hold a large portion of Kontoor Brands’ stock, with varied transactions among firms.,The company’s stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results